Condition
Thrombotic Thrombocytopenic Purpura, Acquired clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Thrombotic Thrombocytopenic Purpura, Acquired clinical trials that are recruiting, in Italy. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Daratumumab for acquired immune thrombotic thrombocytopenic purpura
This project tests whether daratumumab can raise ADAMTS13 activity in adults with acquired (immune) TTP who did not respond to or could not tolerate standard immunosuppressive treatments.
-
TNFAIP3 (A20) gene link to immune-mediated TTP
We will test whether genetic differences near the TNFAIP3 (A20) gene are linked to immune-mediated TTP in people of Italian ancestry and whether lower A20 levels explain that link.
Related topics
Quick answers
How many Thrombotic Thrombocytopenic Purpura, Acquired clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Italy. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.